TradingView
RocketTickers
Aug 26, 2019 10:02 PM

Akorn Receives FDA Approval for Azelastine Hydrochloride Nasal S Long

NASDAQ:AKRX1D

Description

⋅
AKRX: Akorn, Inc.
2019-08-26 13:35:36
Akorn Receives FDA Approval for Azelastine Hydrochloride Nasal Spray, 0.15%
Beyond Technical Analysis
More